Stem Cell Research & TherapyNeurosciencePeer-reviewed journal article
Altered therapeutic capacities of olfactory ensheathing cells caused by a lesion in an autologous transplantation model for the treatment of spinal cord injury.
Quentin DelarueiD, Matthis Brodier, Pauline NeveuiD, Laurine Moncomble, Clémence Raimond, Amandine Robac, Alizée Hugede, Axelle Blondin, Fannie Semprez, Pamela Lecras, Gaëtan RiouiD, Nicolas GuéroutiD
- Citations
- 4
- FWCI
- 2.64
- Field percentile
- top 10%
Abstract
Spinal cord injury (SCI) causes irreversible loss of motor, sensory, and autonomic functions and currently has no cure. Beyond local damage, SCI induces systemic inflammation, including cerebral inflammation that impairs neurogenesis. While cell therapies show promising effects in animal models, such as scar reduction and neuroprotection, their benefits in humans remain limited. One key difference lies in the transplantation strategy: animals receive healthy donor cells, whereas humans require autologous transplants. This led us to investigate how the lesion context affects the neuro-reparative potential of olfactory ensheathing cells (OECs) harvested from olfactory bulbs. To this end, we cultured OECs from healthy animals and from animals that had undergone SCI one week earlier. We then transplanted both types of OECs into recipient animals after SCI for therapeutic purposes. Using functional sensory-motor studies, histological and gene expression analyses, we were able to demonstrate for the first time that the lesion negatively affects the therapeutic properties of cells used to treat SCI. Indeed, transplantation of cells from previously injured animals does not modulate the fibrotic and glial scar, or the demyelinated areas at the lesion site, and therefore fails to improve functional recovery; unlike cells derived from healthy donors. Moreover, our in vitro studies show that cells derived from SCI animals secrete pro-inflammatory molecules that promote the polarization of microglia toward a pro-inflammatory phenotype. Altogether, these innovative findings provide new insights into the potential of cell transplantation in the context of autologous therapy after SCI. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=147 HEIGHT=200 SRC="FIGDIR/small/660789v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@2e9b52org.highwire.dtl.DTLVardef@1d75bfaorg.highwire.dtl.DTLVardef@1d7af58org.highwire.dtl.DTLVardef@138f1b8_HPS_FORMAT_FIGEXP M_FIG C_FIG
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lesion-induced impairment of therapeutic capacities of olfactory ensheathing cells in an autologous transplantation model for treatment of spinal cord injury
Quentin Delarue, Matthis Brodier, … Nicolas Guérout·bioRxiv·Apr 19, 2024
- Activation of Endogenous Spinal Cord Stem Cell Mediates Recovery Induced by Olfactory Ensheathing Cell Transplantation Following Spinal Cord Injury
Quentin Delarue, Axel Honoré, … Nicolas Guérout·bioRxiv·Jul 22, 2025
- Effects of estrogen on Survival and Neuronal Differentiation of adult human olfactory bulb neural stem Cells Transplanted into Spinal Cord Injured Rats
S Rezk, Asma Althani, … Hany E. S. Marei·bioRxiv·Mar 8, 2019
- Olfactory ensheathing cells from adult female rats are hybrid glia that promote neural repair
Patricia E. Phelps, Sung Min Ha, … Xia Yang·eLifePeer-reviewed·Apr 29, 2025
- Transplanted Autologous Neural Stem Cells Show Promise in Restoring Motor Function in Monkey Spinal Cord Injury
Razieh Jaberi, Reza Jabbari, … Sahar Kiani·bioRxiv·May 6, 2023
- Long-term mouse spinal cord organotypic slice culture as a platform for validating cell transplantation in spinal cord injury
Francesca Merighi, Sara De Vincentiis, … Vittoria Raffa·Journal of Visualized ExperimentsPeer-reviewed·Apr 12, 2024